GO
Loading...

Cramer's Stop Trading: GW Pharma becoming 'non-speculative'

Tuesday, 17 Jun 2014 | 9:55 AM ET

GW Pharmaceuticals is developing effective treatments based on chemical cannabinoids found in marijuana to treat seizures. CNBC's Jim Cramer looks at reports of promising results from its drug Epidiolex.